Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Robert B. Mboizi"'
Autor:
Robert B. Mboizi, Muhammed O. Afolabi, Michael Okoye, Beate Kampmann, Anna Roca, Olubukola T. Idoko
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 13, Iss 9, Pp 2185-2191 (2017)
Communicating essential research information to low literacy research participants in Africa is highly challenging, since this population is vulnerable to poor comprehension of consent information. Several supportive materials have been developed to
Externí odkaz:
https://doaj.org/article/5fd3f7440a9d4881b254d258bf84ecc8
Autor:
Anna Turkova, Genevieve H. Wills, Eric Wobudeya, Chishala Chabala, Megan Palmer, Aarti Kinikar, Syed Hissar, Louise Choo, Philippa Musoke, Veronica Mulenga, Vidya Mave, Bency Joseph, Kristen LeBeau, Margaret J. Thomason, Robert B. Mboizi, Monica Kapasa, Marieke M. van der Zalm, Priyanka Raichur, Perumal K. Bhavani, Helen McIlleron, Anne-Marie Demers, Rob Aarnoutse, James Love-Koh, James A. Seddon, Steven B. Welch, Stephen M. Graham, Anneke C. Hesseling, Diana M. Gibb, Angela M. Crook
Publikováno v:
The New England Journal of Medicine, 386, 911-922
The New England Journal of Medicine, 386, 10, pp. 911-922
The New England Journal of Medicine, 386, 10, pp. 911-922
Contains fulltext : 249121.pdf (Publisher’s version ) (Open Access) BACKGROUND: Two thirds of children with tuberculosis have nonsevere disease, which may be treatable with a shorter regimen than the current 6-month regimen. METHODS: We conducted a
Autor:
Beate Kampmann, Michael Okoye, Anna Roca, Robert B. Mboizi, Muhammed O. Afolabi, Olubukola T. Idoko
Publikováno v:
Human Vaccines & Immunotherapeutics. 13:2185-2191
Communicating essential research information to low literacy research participants in Africa is highly challenging, since this population is vulnerable to poor comprehension of consent information. Several supportive materials have been developed to
Autor:
Olubukola T. Idoko, Robert B. Mboizi, Michael Okoye, France Laudat, Bubacarr Ceesay, John Z. Liang, Natacha Le Dren-Narayanin, Kathrin U. Jansen, Alejandra Gurtman, Kimberly J. Center, Daniel A. Scott, Beate Kampmann, Anna Roca
Background This open-label randomized controlled trial in infants compared safety, tolerability, and immunogenicity of the 13-valent pneumococcal conjugate vaccine (PCV13) formulated with the preservative 2-phenoxyethanol (2-PE) in a multidose vial (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a92cc10bd56ef54ff6ce0b193204a918
https://researchonline.lshtm.ac.uk/id/eprint/4650139/1/Idoko_etal_2017_Immunogenicity-and-safety-of-13-valent-pneumococcal-conjugate-vaccine.pdf
https://researchonline.lshtm.ac.uk/id/eprint/4650139/1/Idoko_etal_2017_Immunogenicity-and-safety-of-13-valent-pneumococcal-conjugate-vaccine.pdf
Autor:
Jennifer B. Harris, Martin O. C. Ota, Olubukola T. Idoko, Daniel C. Ehlman, Schadrac C. Agbla, Terri B. Hyde, Lee M. Hampton, Robert B. Mboizi, Beate Kampmann, Aaron S. Wallace, Dawda Sowe
Publikováno v:
Vaccine. 34(41)
Background As the World Health Organization (WHO) currently recommends that children be protected against 11 different pathogens, it is becoming increasingly necessary to administer multiple injectable vaccines during a single immunization visit. In